NCT02648490 2019-07-30An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid CancersHenlix, IncPhase 1 Completed19 enrolled
NCT02257476 2017-02-07Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid TumorsEmory UniversityPhase 1 Completed22 enrolled